Loading patent…
AssigneeKyungpook National University Industry-Academic Cooperation Foundation
InventorsJae Sung Bae, Hee Kyung Jin, Ju Youn Lee, Min Hee Park
Estimating the term…
The present invention relates to a novel use for HDL-ApoM-S1P (a high density lipoprotein in which apolipoprotein M is impregnated with sphingosine-1-phosphate), and more particularly, to using HDL-ApoM-S1P to prevent, improve, or treat degenerative brain disorders (in particular, Alzheimer's disease), cognitive disorders, learning disabilities, and memory disorders, and using HDL-ApoM-S1P to improve cognitive ability, learning ability, and memory. The HDL-ApoM-S1P according to the present invention not only alleviates neuroinflammation but also significantly exhibits improvement effects of cognitive disorder, learning disability, and memory disorder with respect to individuals suffering from degenerative brain disorders (in particular, Alzheimer's disease), and exhibits an effect of greatly reducing amyloid beta and tau deposition. Moreover, increased HDL-ApoM-S1P in the body also has an excellent effect of improving the cognitive, learning, and memory abilities of non-disabled individuals.
A method for treating Alzheimer's disease, the method comprising administering an effective amount of a composition comprising a high density lipoprotein (HDL-ApoM-S1P) in which apolipoprotein M is impregnated with sphingosine-1-phosphate as an active ingredient to an individual in need thereof.
A method for treating Alzheimer's disease associated cognitive disorders, learning disabilities, and memory disorders, the method comprising administering an effective amount of a composition comprising a high density lipoprotein (HDL-ApoM-S1P) in which apolipoprotein M is impregnated with sphingosine-1-phosphate as an active ingredient to an individual in need thereof.
Dependencies are inferred from the claim text.